Globus Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Globus Medical Inc 's inventory turnover ratio sequentially decreased to 1.27 in the second quarter 2026, otherwise the ratio remained above the average, as GMED's markets remain strong.Globus Medical Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 287 days, from 281 days, in the Mar 31 2026 quarter.

Within Healthcare sector 287 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1105 in the first quarter 2026, to 1775.

GMED Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Globus Medical Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GMED Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	5.02 %	16.43 %	15.18 %	7.5 %	0.22 %
Y / Y Cost of Sales Growth	-2.94 %	19.79 %	-0.88 %	-6.65 %	-4.34 %
Inventory Turnover Ratio (TTM)	1.27	1.3	1.29	1.34	1.39
GMED's Total Ranking	# 1775	# 1105	# 1088	# 797	# 1038
Average inventory processing period	287	282	283	272	262
Seq. Inventory Growth	4.96 %	1.75 %	-1.59 %	-0.08 %	16.35 %
Seq. Cost of Sales Growth	3.15 %	-10.36 %	3.4 %	1.51 %	27.31 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 132
Healthcare Sector	# 288
Overall Market	# 1775

Inventory Turnover Ratio Statistics
High	Average	Low
1.74	1.25	0.76
(Dec 31 2012)		(Sep 30 2023)

GMED Company Profile >> Back to GMED Efficiency Comparisons >> Compare GMED Inventory Turnover Ratio to its Competitors

Financial Statements
Globus Medical Inc 's Inventories	$ 811 Millions	Visit GMED's Balance sheet
Globus Medical Inc 's Cost of Revenues TTM	$ 989 Millions	Visit GMED's Income Statement
What are GMED's Sales?		Visit GMED's Sales by Segment

Other Inventory Turnover Ratios
Globus Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GMED's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GMED's Competitors
Inventory Turnover Ratio for GMED's Suppliers
Inventory Turnover Ratio for GMED's Customers

You may also want to know
GMED's Sales Growth Rates	GMED's Pe Price to earnings ratio	GMED's Receivables Turnover Ratio	GMED's Stock Quote
GMED's Net Income Growth Rates	GMED's Ps Price to Sales ratio	GMED's Sales per Employee	GMED's Asset Turnover Ratio
GMED's Net Margin	GMED's Pb Price to Book ratio	GMED's Financial Strength Ratios	GMED's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Gilead Sciences Inc	3.35	$ 6,217.000 Millions	$ 1,857 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Exelixis Inc	3.28	$ 85.665 Millions	$ 26 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Solventum Corporation	3.22	$ 3,421.000 Millions	$ 1,061 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Zevra Therapeutics Inc	3.14	$ 6.180 Millions	$ 2 Millions
Prestige Consumer Healthcare Inc	3.13	$ 513.522 Millions	$ 164 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Becton Dickinson And Company	3.09	$ 11,161.000 Millions	$ 3,615 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Revvity Inc	2.98	$ 1,136.473 Millions	$ 381 Millions
Amneal Pharmaceuticals Inc	2.98	$ 1,891.689 Millions	$ 635 Millions
Akebia Therapeutics Inc	2.96	$ 44.632 Millions	$ 15 Millions
Msa Safety Inc	2.92	$ 1,021.036 Millions	$ 350 Millions
Ligand Pharmaceuticals Incorporated	2.91	$ 32.387 Millions	$ 11 Millions
Logicmark Inc	2.83	$ 3.881 Millions	$ 1 Millions
Iovance Biotherapeutics inc	2.81	$ 152.872 Millions	$ 54 Millions
Dexcom Inc	2.81	$ 1,864.400 Millions	$ 663 Millions
Livanova Plc	2.79	$ 468.065 Millions	$ 168 Millions
Merck and Co Inc	2.79	$ 17,996.000 Millions	$ 6,447 Millions
Inspiremd Inc	2.78	$ 8.847 Millions	$ 3 Millions
Dentsply Sirona Inc	2.77	$ 1,839.000 Millions	$ 663 Millions
Ani Pharmaceuticals Inc	2.69	$ 387.398 Millions	$ 144 Millions
Neogen Corporation	2.67	$ 461.474 Millions	$ 173 Millions
International Stem Cell Corporation	2.61	$ 4.285 Millions	$ 2 Millions
Biomerica Inc	2.59	$ 4.091 Millions	$ 2 Millions

Date modified: 2026-09-08T17:55:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.